May 14 (Reuters) - Iconovo AB ICO.ST :
* ICONOVO EXTENDS AGREEMENT WITH AMNEAL FOR GENERIC
SYMBICORT TO
COVER KEY MARKETS U.S. AND CHINA, AS WELL AS NORDIC SALES RIGHTS
* ITS COLLABORATION WITH U.S. PHARMACEUTICAL COMPANY AMNEAL
IS
EXPANDING TO INCLUDE ADDITIONAL TERRITORIES THAT LEAD TO
ANNOUNCED POTENTIAL FOR FUTURE ANNUAL ROYALTY INCOME MORE THAN
DOUBLING TO USD 13.2 - 26.4 MILLION
Source text for Eikon: ID:nMFN9SwyBM
Further company coverage: ICO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))